Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis

24Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In numerous types of cancer, the primary tumor site can show a correlation with disease behavior and survival outcomes. In salivary gland tumors (SGTs) this association remains controversial. This study assessed the association between primary sites of SGTs and prognosis. Studies from five databases were assessed and a meta-analysis was performed using studies that presented 95 % confidence interval (95 % CI), hazard ratio (HR) and survival analysis. Gathered information from 46,361 patients showed that site had a prognostic impact on SGTs. Tumors involving minor salivary glands showed worse overall survival (HR = 1.60; 95 % CI = 1.17–2.19; p = 0.003), disease-specific survival (HR=1.63; 95 % CI = 1.12−2.37; p = 0.01), and cause-specific survival (HR=2.10; 95 % CI = 1.72−2.55; p = 0.00001). Tumors from major salivary glands showed better recurrence-free survival (HR=2.31; 95 % CI = 1.77−3.02; p = 0.00001), and locoregional control of disease (HR=2.66; 95 % CI = 1.20−5.91; p = 0.02). Our results showed that the primary site of SGTs has an impact on patient prognosis.

Cite

CITATION STYLE

APA

dos Santos, E. S., Rodrigues-Fernandes, C. I., Speight, P. M., Khurram, S. A., Alsanie, I., Costa Normando, A. G., … Leme, A. F. P. (2021, June 1). Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. Elsevier Ireland Ltd. https://doi.org/10.1016/j.critrevonc.2021.103352

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free